Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024

Geneva, Switzerland, May 31, 2024 - Addex Therapeutics , a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological...

Related Keywords

United States ,Switzerland ,Geneva ,Genè ,American ,Swiss ,Mikhail Kalinichev ,Tim Dyer ,Mike Sinclair ,Nasdaq ,Swiss Exchange ,Janssen Pharmaceuticals Inc ,Translational Science ,Addex Therapeutics ,Conference Call ,Participant Dial In ,American Depositary Shares ,Forward Looking Statements ,Private Securities Litigation Reform Act ,Addex Therapeutic Annual Report ,Addex Therapeutic ,